Life Science And Chemical Instrumentation Market Report 2026

Life Science And Chemical Instrumentation Market Overview

• Life Science And Chemical Instrumentation market size has reached to $61.82 billion in 2025 • Expected to grow to $90.58 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Increased R&D Investments Propel Growth In The Life Science And Chemical Instrumentation Market • Market Trend: Advancements In Analytical Instruments Drive Innovation In The Life Science And Chemical Instrumentation Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Life Science And Chemical Instrumentation Market?

Life science and chemical instrumentation refer to medical devices that are utilized to serve the purpose of a quality test of the products, control and monitor the process in manufacturing plants, test the quality of food products, and handle laboratory information. These are used to monitor and regulate processes in research and development activities in industrial laboratories, the pharmaceutical industry, biotechnology, and academic sectors. The major technologies involved in life science and chemical instrumentations are polymerase chain reaction (PCR), DNA sequencers and amplifiers, flow cytometry, spectroscopy, electrophoresis, chromatography, centrifuges, and other technologies. Polymerase chain reaction (PCR) is a laboratory technique for quickly making (amplifying) millions to billions of copies of a certain DNA segment, which may subsequently be analyzed in more detail. These are used in several applications, such as cell culture and cell therapy, cancer research, drug discovery, genomics, in vitro fertilization, bioprocess, metabolomics, proteomics, and other applications. These life science and chemical instrumentations are used by several end-users, such as hospitals and diagnostic centers, pharmaceutical and biotechnology companies, contract research organization (CRO), academia and research institutes.

What Is The Life Science And Chemical Instrumentation Market Growth Forecast?

The life science and chemical instrumentation market size is expected to see strong growth in the next few years. It will grow to $90.58 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing adoption of advanced omics technologies, rising investments in personalized medicine research, expansion of digital laboratories, growing focus on regulatory compliance automation, increasing demand for real-time analytical insights. Major trends in the forecast period include increasing adoption of automated analytical instruments, rising demand for high-throughput testing systems, growing integration of laboratory information systems, expansion of precision measurement technologies, enhanced focus on data integrity and compliance.

Global Life Science And Chemical Instrumentation Market Segmentation

1) By Technology: Polymerase Chain Reaction (PCR), DNA Sequencers and Amplifiers, Flow Cytometry, Spectroscopy, Electrophoresis, Chromatography, Centrifuges, Other Technologies 2) By Application: Cell Culture And Cell Therapy, Cancer Research, Drug Discovery, Genomics, In Vitro Fertilization, Bioprocess, Metabolomics, Proteomics, Other Applications 3) By End Users: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Contract Research Organization (CRO), Academia And Research Institutes Subsegments: 1) By Polymerase Chain Reaction (PCR): Real-Time PCR, Digital PCR, Standard PCR 2) By DNA Sequencers And Amplifiers: Next-Generation Sequencing (NGS), Sanger Sequencing 3) By Flow Cytometry: Cell Sorting, Multiparameter Analysis 4) By Spectroscopy: UV-Vis Spectroscopy, Mass Spectrometry, Infrared Spectroscopy 5) By Electrophoresis: Gel Electrophoresis, Capillary Electrophoresis 6) By Chromatography: Gas Chromatography (GC), High-Performance Liquid Chromatography (HPLC) 7) By Centrifuges: Benchtop Centrifuges, Ultracentrifuges 8) By Other Technologies: Microarray Technology, Immunoassay

What Is The Driver Of The Life Science And Chemical Instrumentation Market?

The growing investments in research and development is expected to propel the growth of the life science and chemical instrumentation market going forward. Research and development refer to the systematic and creative work undertaken to increase scientific knowledge and develop new or improved products, technologies, and processes. Research and development is rising due to increasing government funding aimed at accelerating technological innovation to maintain economic competitiveness. The life science and chemical instrumentation industry is witnessing increased demand as the rapid expansion of research and development pushes companies to adopt advanced analytical, detection, and measurement technologies to support high-precision scientific work. For instance, in September 2025, according to Eurostat, the Luxembourg-based government agency, research and development expenditure in the European Union reached 2.26% of GDP in 2023, up from 2.22% in 2022. Therefore, the growing investments in research and development is driving the demand for the life science and chemical instrumentation industry.

Key Players In The Global Life Science And Chemical Instrumentation Market

Major companies operating in the life science and chemical instrumentation market are Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., Waters Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Shimadzu Corporation, General Electric Healthcare LLC, Hitachi High-Technologies Corporation, JEOL Ltd., Oxford Instruments PLC, Rigaku Corporation, Sigma-Aldrich Corporation, SRI Instruments, Analytik Jena AG, Biochrom Ltd., BioTek Instruments Inc., Cole-Parmer Instrument Company LLC, Eppendorf AG, Harvard Bioscience Inc., HORIBA Ltd., Labconco Corporation, Mettler-Toledo International Inc., New England Biolabs Inc., QIAGEN N.V.

Global Life Science And Chemical Instrumentation Market Trends and Insights

Major companies operating in the life science and chemical instrumentation market are focusing on incorporating scalable and energy-efficient analytical technologies such as next-generation gas chromatography (GC) systems to enhance laboratory efficiency, analytical flexibility, and sustainability. Next-generation GC systems are advanced analytical platforms designed to separate, detect, and quantify chemical compounds with higher throughput, lower energy use, and smarter automation, enabling capabilities such as intelligent operation, reduced consumable usage, and seamless integration with complementary instruments. For instance, in October 2023, Shimadzu Corporation, a Japan-based manufacturer of analytical instruments launched Brevis GC-2050. The instrument is designed to be highly scalable, allowing connections to auto-samplers, mass spectrometers, and other accessories, all while maintaining a slim width of just 35 cm. It also boasts a 30% reduction in energy consumption compared to traditional models and minimizes helium usage, promoting environmental sustainability. The Brevis GC-2050 is a compact and advanced gas chromatography system that includes intelligent automated features.

What Are Latest Mergers And Acquisitions In The Life Science And Chemical Instrumentation Market?

In August 2024, Spectris, a UK-based Instrumentation company acquired Micromeritics for $600 million. The acquisition aims to create a leading global player in particle characterization by utilizing Micromeritics' expertise in analytical instrumentation, enhancing Spectris’ offerings in high-growth markets like clean technology. Through this acquisition, Spectris intends to deliver a comprehensive suite of solutions that covers the entire customer workflow, from research and development to quality control. Micromeritics is a Georgia-based manufacturer of instruments for measuring surface area, porosity, density, and chemical activity.

Regional Outlook

North America was the largest region in the life science and chemical instrumentation market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Life Science And Chemical Instrumentation Market?

The life science and chemical instrumentation market consists of sales of medical equipment such as liquid chromatography, molecular spectroscopy, electron microscopes, and cell analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.